Xeris Biopharma Holdings, Inc. (XERS) Income Annual - Discounting Cash Flows
XERS
Xeris Biopharma Holdings, Inc.
XERS (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing 2025-11-06 2025-03-06 2024-03-06 2023-03-08 2022-03-11 2022-03-11 2020-12-31 2019-03-06 2017-12-31 2016-12-31
Revenue 266.1 203.1 163.9 110.2 49.59 20.43 2.72 2.46 1.56 1.07
Cost of Revenue 43.81 36.83 28.64 22.63 13.32 9.33 1.6 0.042 0.004 0.008
Gross Profit 222.3 166.2 135.3 87.61 36.27 11.11 1.12 2.42 1.55 1.07
Operating Expenses 212.5 199.9 179.3 169.6 151.4 94.65 123.5 61.77 28.18 14.3
Research & Development 29.38 25.56 22.34 20.97 25.16 20.92 60.44 40.65 20.17 10.24
Selling, General and Administrative 175 163.5 146.1 137.7 125.7 73.73 63.06 21.11 8.02 4.06
Other Operating Expenses 8.13 10.84 10.84 10.84 0.55 0 0 0 0 0
Operating Income 9.8 -33.65 -44.01 -81.94 -115.2 -83.55 -122.4 -59.34 -26.63 -13.23
Net Non-Operating Interest -25.44 -27.85 -21.86 -11.52 -6.87 -2.9 -4.35 -0.932 0.122 0.003
Interest Income 4.19 5.32 4.75 2.58 0.313 4.46 2.81 1.61 0.124 0.005
Interest Expense 29.63 33.17 26.61 14.1 7.18 7.36 7.16 2.54 0.002 0.002
Equity & Other Income/(Expense) 0.001 4.4 2.36 -2.62 -0.702 -4.81 0.692 0.196 -0.047 0.019
Income Before Tax -15.64 -57.1 -63.5 -96.08 -122.7 -91.25 -126 -60.08 -26.55 -13.21
Income Tax Expense 0 -2.27 -1.25 -1.42 0 -0.11 -0.458 0 0.001 -0.003
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 -0.001 0.003
Net Income -15.64 -54.84 -62.26 -94.66 -122.7 -91.14 -125.6 -60.08 -26.55 -13.21
Depreciation and Amortization 12.63 12.62 13.16 12.67 1.88 1.47 1.08 0.32 0.177 0.116
EBITDA 22.43 -21.02 -30.85 -69.27 -113.3 -82.08 -121.3 -59.02 -26.45 -13.12
Earnings Per Share (EPS) -0.104 -0.37 -0.45 -0.7 -1.55 -2.14 -3.49 -4.99 -13.09 -7.17
Diluted Earnings Per Share -0.104 -0.37 -0.45 -0.7 -1.55 -2.14 -3.49 -4.99 -13.09 -7.17
Weighted Average Shares Outstanding 177.6 146.8 137.7 135.6 79.03 42.64 26.11 12.05 2.03 1.84
Diluted Weighted Average Shares Outstanding 177.6 146.8 137.7 135.6 79.03 42.64 26.11 12.05 2.03 1.84
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program